Publications by authors named "E F Elstner"

Claim this Profile
P
Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.
Boon-Yin Khoo, Kalpanah Nadarajan, Siang-Yian Shim, Noorizan Miswan, Chuan-Bing Zang, Elena Elstner

Mol Med Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of MCF-10A cells with pioglitazone and serum-rich growth medium increases soluble factors in the conditioned medium, likely reducing BT-474 cell growth.
Boon Yin Khoo, Noorizan Miswan, Prabha Balaram, Kalpanah Nadarajan, Elena Elstner

Int J Mol Sci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
Hongyu Liu, Chuanbing Zang, Jan-Hendrik Schefe, Sandra Schwarzlose-Schwarck, Anne-Constanze Regierer, Elena Elstner

Anticancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
Birgit Kraus, Horst Wolff, Erich F Elstner, Jörg Heilmann

Naunyn Schmiedebergs Arch Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.
Chuanbing Zang, Hongyu Liu, Janina Bertz, Kurt Possinger, H Phillip Koeffler, Elena Elstner

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis